Cargando…
The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome
OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxid...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250086/ https://www.ncbi.nlm.nih.gov/pubmed/29699958 http://dx.doi.org/10.4274/jtgga.2018.0001 |
_version_ | 1783372885356707840 |
---|---|
author | Hepşen, Sema Karaköse, Melia Çakal, Erman Öztekin, Sanem Ünsal, İlknur Akhanlı, Pınar Uçan, Bekir Özbek, Mustafa |
author_facet | Hepşen, Sema Karaköse, Melia Çakal, Erman Öztekin, Sanem Ünsal, İlknur Akhanlı, Pınar Uçan, Bekir Özbek, Mustafa |
author_sort | Hepşen, Sema |
collection | PubMed |
description | OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS. MATERIAL AND METHODS: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria were embodied in this study. One hundred six age-matched female volunteers were included in the control group. Characteristics, biochemical parameters, thyroid hormone and autoantibody levels of groups were investigated. RESULTS: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO and anti-TG antibody levels were determined higher in PCOS group significantly (p<0.001). Anti-TPO Ab and anti-TG Ab positivity prevalence of PCOS patients were significantly higher as against to controls (p<0.001; p=0.01). CONCLUSION: Not only thyroid hormone levels but also thyroid autoantibody levels should be screened during the investigation of PCOS and the patients with positive results need to be followed up carefully in the long run. |
format | Online Article Text |
id | pubmed-6250086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-62500862018-11-26 The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome Hepşen, Sema Karaköse, Melia Çakal, Erman Öztekin, Sanem Ünsal, İlknur Akhanlı, Pınar Uçan, Bekir Özbek, Mustafa J Turk Ger Gynecol Assoc Original Investigation OBJECTIVE: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects on comorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted to commentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS. MATERIAL AND METHODS: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria were embodied in this study. One hundred six age-matched female volunteers were included in the control group. Characteristics, biochemical parameters, thyroid hormone and autoantibody levels of groups were investigated. RESULTS: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO and anti-TG antibody levels were determined higher in PCOS group significantly (p<0.001). Anti-TPO Ab and anti-TG Ab positivity prevalence of PCOS patients were significantly higher as against to controls (p<0.001; p=0.01). CONCLUSION: Not only thyroid hormone levels but also thyroid autoantibody levels should be screened during the investigation of PCOS and the patients with positive results need to be followed up carefully in the long run. Galenos Publishing 2018-12 2018-11-15 /pmc/articles/PMC6250086/ /pubmed/29699958 http://dx.doi.org/10.4274/jtgga.2018.0001 Text en ©Copyright 2018 by the Turkish-German Gynecological Education and Research Foundation http://creativecommons.org/licenses/by/2.5/ Journal of the Turkish-German Gynecological Association published by Galenos Publishing House. |
spellingShingle | Original Investigation Hepşen, Sema Karaköse, Melia Çakal, Erman Öztekin, Sanem Ünsal, İlknur Akhanlı, Pınar Uçan, Bekir Özbek, Mustafa The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title | The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title_full | The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title_fullStr | The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title_full_unstemmed | The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title_short | The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
title_sort | assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250086/ https://www.ncbi.nlm.nih.gov/pubmed/29699958 http://dx.doi.org/10.4274/jtgga.2018.0001 |
work_keys_str_mv | AT hepsensema theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT karakosemelia theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT cakalerman theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT oztekinsanem theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT unsalilknur theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT akhanlıpınar theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT ucanbekir theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT ozbekmustafa theassessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT hepsensema assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT karakosemelia assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT cakalerman assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT oztekinsanem assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT unsalilknur assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT akhanlıpınar assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT ucanbekir assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome AT ozbekmustafa assessmentofthyroidautoantibodylevelsineuthyroidpatientswithpolycysticovarysyndrome |